flufenamic acid has been researched along with niflumic acid in 56 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (8.93) | 18.7374 |
1990's | 18 (32.14) | 18.2507 |
2000's | 14 (25.00) | 29.6817 |
2010's | 17 (30.36) | 24.3611 |
2020's | 2 (3.57) | 2.80 |
Authors | Studies |
---|---|
Chang, TK; Ensom, MH; Kiang, TK | 1 |
Herz, JM; Hu, H; Tian, J; Wang, C; Wood, JD; Xiao, R; Zhu, MX; Zhu, Y | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Dai, L; Garg, V; Sanguinetti, MC | 1 |
Garg, P; Sanguinetti, MC | 1 |
Bartlett, SJ; Bauche, A; Fliegert, R; Guse, AH; Harneit, A; Kirchberger, T; Moreau, C; Potter, BV; Swarbrick, JM; Yorgan, T | 1 |
Bennis, K; Ducki, S; Lesage, F; Vivier, D | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Alexandrov, K; Capon, RJ; Cooper, MA; Fontaine, F; Francois, M; Gambin, Y; Jauch, R; Koopman, P; Lua, L; Mamidyala, S; Moustaqil, M; Narasimhan, K; Overman, J; Prokoph, N; Robertson, AAB; Salim, A; Sierecki, E; Zuegg, J | 1 |
Adihou, H; Akbarzadeh, M; Dötsch, L; Friese, A; Guéret, SM; Hahne, G; Hong, W; Kang, C; Karatas, H; Metz, M; Nowak, C; Pahl, A; Pobbati, AV; Sievers, S; Thavam, S; Waldmann, H; Yihui Ng, E; Zinken, S | 1 |
Audran, M; Boiteau, HL; Carlier, N; Hamelin, JP; Prost, A; Rossel-Renac, F | 1 |
Leynadier, F; Perrault, M | 1 |
Collas, P | 1 |
Onoda, T; Shichikawa, K | 1 |
Cook, DI; Poronnik, P; Ward, MC | 1 |
Chao, AC; Mochizuki, H | 1 |
Aylwin, M; White, MM | 1 |
Dahlem, D; Englert, HC; Gögelein, H; Lang, HJ | 1 |
Musumeci, S; Raciti, R; Romano, L; Scuteri, A | 1 |
Ottolia, M; Toro, L | 1 |
Clauss, W; Liebold, KM; Reifarth, FW; Uhr, U; Weber, WM | 1 |
Dani, JA; Dineley-Miller, K; Patrick, JW; Séguéla, P; Wadiche, J | 1 |
Martin, SC; Shuttleworth, TJ | 1 |
Oortgiesen, M; Vijverberg, HP; Zwart, R | 1 |
Busch, AE; Herzer, T; Lang, F; Raber, G; Schmidt, F; Wagner, CA; Waldegger, S | 1 |
Greenwood, IA; Large, WA | 1 |
De Smet, P; Droogmans, G; Eggermont, J; Nilius, B; Van Driessche, W; Voets, T; Wei, L | 1 |
Dixon, JE; McKinnon, D; Wang, HS | 1 |
Benos, DJ; DuVall, MD; Fuller, CM; Ji, HL; Patton, HK; Satterfield, CL | 1 |
Hamill, OP; McBride, DW; Zhang, Y | 1 |
Kinnamon, SC; Lin, W; McPheeters, M; Mierson, S; Wladkowski, SL | 1 |
Bracht, A; Ishii-Iwamoto, EL; Kelmer-Bracht, AM; Lopez, CH; Sampaio, E; Yamamoto, NS | 1 |
Baures, PW; Kelly, JW; Oza, VB; Peterson, SA | 1 |
Polásek, M; Pospísilová, M; Urbánek, M | 1 |
Katz, U; Nagel, W; Somieski, P | 1 |
Aspeslagh, S; Braet, K; Evans, WH; Leybaert, L; Martin, PE; Vandamme, W; Willecke, K | 1 |
Hotta, A; Kim, YC; Kito, Y; Nakamura, E; Suzuki, H; Yamamoto, Y | 1 |
Bauer-Brandl, A; Perlovich, GL; Surov, AO | 1 |
Gaganis, P; Knights, KM; Miners, JO | 1 |
Babini, E; Camerino, DC; Liantonio, A; Picollo, A; Pusch, M | 1 |
Arendshorst, WJ; Fellner, SK | 1 |
Guan, BC; Jiang, ZG; Ma, KT; Yang, YQ; Zhao, H | 1 |
Bates, DO; Foster, RR; Mathieson, PW; Saleem, MA; Satchell, SC; Welsh, GI; Ye, Y; Zadeh, MA | 1 |
Choi, JJ; Choi, S; Jin, M; Jun, JY; Kim, DH; Kim, SH; Koh, JW; Lee, I; Pyo, MY; Son, JP; Son, M | 1 |
Habjan, S; Vandenberg, RJ | 1 |
Perlovich, GL; Surov, AO; Szterner, P; Zielenkiewicz, W | 1 |
Domańska, U; Pelczarska, A; Pobudkowska, A | 2 |
Choi, S; Jun, JY; Kim, MY; Kim, YD; Koh, JW; Park, CG; So, I; Yeum, CH | 1 |
Han, S; Han, SE; Jung, BK; Kim, BJ; Kim, JS; Kwon, YK; Nah, SY; Nam, JH | 1 |
Bozzolan, F; Debernard, S; Demondion, E; François, A; Grauso, M; Lucas, P | 1 |
Guan, BC; Jiang, ZG; Li, L; Li, XZ; Ma, KT; Si, JQ; Zhang, ZS; Zhao, L | 1 |
Du, X; Gamper, N; Gao, H; Huang, D; Liu, Y; Qi, J; Xu, J; Zhang, H | 1 |
Hatzidimitriou, AG; Kefala, LA; Kessissoglou, DP; Papadopoulos, AN; Perdih, F; Psomas, G; Tsiliou, S; Turel, I | 1 |
Carter, JM; Diaz, MR; Gigante, ED; Landin, JD; Rieger, SP; Werner, DF | 1 |
Kumar, A; Misra, G; Pal, R | 1 |
2 review(s) available for flufenamic acid and niflumic acid
Article | Year |
---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
Topics: Arrhythmias, Cardiac; Depression; Epilepsy; Humans; Inflammation; Models, Molecular; Molecular Structure; Neuroprotective Agents; Pain; Potassium Channels, Tandem Pore Domain; Structure-Activity Relationship | 2016 |
2 trial(s) available for flufenamic acid and niflumic acid
Article | Year |
---|---|
[An anti-inflammatory association in oral surgery. A report on 90 cases].
Topics: Adult; Clinical Trials as Topic; Female; Flufenamic Acid; Humans; Male; Nicotinic Acids; Niflumic Acid; Postoperative Complications; Surgery, Oral | 1977 |
[Effect of niflumic acid on chronic rheumatoid arthritis].
Topics: Adolescent; Adult; Arthritis, Rheumatoid; Clinical Trials as Topic; Drug Evaluation; Female; Flufenamic Acid; Humans; Male; Middle Aged; Nicotinic Acids; Niflumic Acid | 1976 |
52 other study(ies) available for flufenamic acid and niflumic acid
Article | Year |
---|---|
Activation of TRPA1 channels by fenamate nonsteroidal anti-inflammatory drugs.
Topics: Animals; Ankyrins; Anti-Inflammatory Agents, Non-Steroidal; Calcium Channels; Cell Line; Fenamates; Humans; Membrane Potentials; Mice; Molecular Structure; Oocytes; Patch-Clamp Techniques; Rats; TRPA1 Cation Channel; TRPC Cation Channels; TRPM Cation Channels; TRPV Cation Channels; Xenopus laevis | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Activation of Slo2.1 channels by niflumic acid.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Ion Channel Gating; Membrane Potentials; Niflumic Acid; Oocytes; Potassium Channels; Potassium Channels, Sodium-Activated; Protein Conformation; Sodium; Structure-Activity Relationship; Xenopus | 2010 |
Structure-activity relationship of fenamates as Slo2.1 channel activators.
Topics: Animals; Cyclooxygenase Inhibitors; Female; Fenamates; Humans; Ibuprofen; In Vitro Techniques; Large-Conductance Calcium-Activated Potassium Channel alpha Subunits; Niflumic Acid; Oocytes; ortho-Aminobenzoates; Patch-Clamp Techniques; Point Mutation; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Sodium-Activated; Structure-Activity Relationship; Xenopus laevis | 2012 |
Structure-activity relationship of adenosine 5'-diphosphoribose at the transient receptor potential melastatin 2 (TRPM2) channel: rational design of antagonists.
Topics: Adenosine Diphosphate Ribose; Dose-Response Relationship, Drug; Drug Design; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship; TRPM Cation Channels | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Small-Molecule Inhibitors of the SOX18 Transcription Factor.
Topics: Animals; Binding Sites; Biological Products; Chlorocebus aethiops; COS Cells; DNA; Drug Design; Genes, Reporter; Immunoglobulin J Recombination Signal Sequence-Binding Protein; Inhibitory Concentration 50; Mice; Nucleic Acid Conformation; Protein Binding; Protein Interaction Maps; Protein Structure, Tertiary; Salicylic Acid; Small Molecule Libraries; SOXF Transcription Factors; Structure-Activity Relationship; Transcriptional Activation | 2017 |
Discovery of Covalent Inhibitors Targeting the Transcriptional Enhanced Associate Domain Central Pocket.
Topics: Dose-Response Relationship, Drug; Drug Discovery; Fluorescence; Humans; Models, Molecular; Molecular Structure; Pyrones; Small Molecule Libraries; Structure-Activity Relationship; Sulfhydryl Compounds; Transcription Factors | 2020 |
[Ionized fluorine in the plasma and urine of subjects treated with organofluorine drugs prescribed in rheumatology].
Topics: Anti-Inflammatory Agents; Flufenamic Acid; Fluorine; Humans; Nicotinic Acids; Niflumic Acid; ortho-Aminobenzoates; Rheumatic Diseases; Sulindac | 1979 |
[Anti-inflammatory agents in current therapeutics].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Asthma; Bursitis; Colchicine; Collagen Diseases; Dexamethasone; Drug Hypersensitivity; Drug Interactions; Flufenamic Acid; Gastrointestinal Hemorrhage; Hallucinations; Humans; Mefenamic Acid; Niflumic Acid; Phenylbutazone; Spondylitis, Ankylosing; Tendinopathy; Triamcinolone; Vertigo | 1975 |
Intracellular Ca2+ release by flufenamic acid and other blockers of the non-selective cation channel.
Topics: Animals; Animals, Newborn; Calcium; Cell Line; Flufenamic Acid; Ion Channels; Mefenamic Acid; Mice; Molecular Structure; Niflumic Acid | 1992 |
Niflumic and flufenamic acids are potent inhibitors of chloride secretion in mammalian airway.
Topics: Animals; Cattle; Cells, Cultured; Chloride Channels; Chlorides; Dogs; Epithelial Cells; Epithelium; Flufenamic Acid; Ion Channels; Membrane Proteins; Niflumic Acid; Oocytes; Trachea; Xenopus laevis | 1992 |
Niflumic and flufenamic acids are potent reversible blockers of Ca2(+)-activated Cl- channels in Xenopus oocytes.
Topics: Animals; Calcimycin; Calcium; Chloride Channels; Chlorides; Dose-Response Relationship, Drug; Female; Flufenamic Acid; Ion Channels; Kinetics; Membrane Proteins; Nicotinic Acids; Niflumic Acid; Oocytes; Xenopus | 1990 |
Flufenamic acid, mefenamic acid and niflumic acid inhibit single nonselective cation channels in the rat exocrine pancreas.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cations; Electric Conductivity; Flufenamic Acid; In Vitro Techniques; Ion Channels; Mefenamic Acid; Nicotinic Acids; Niflumic Acid; Pancreas; Rats | 1990 |
[Interaction of anti-inflammatory substances with the transport of 35SO4 in red blood cells].
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Adult; Biological Transport; Erythrocytes; Flufenamic Acid; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Nicotinic Acids; Niflumic Acid; Sulfates | 1987 |
Potentiation of large conductance KCa channels by niflumic, flufenamic, and mefenamic acids.
Topics: Animals; Biophysical Phenomena; Biophysics; Calcium; Charybdotoxin; Electrochemistry; Flufenamic Acid; In Vitro Techniques; Kinetics; Mefenamic Acid; Niflumic Acid; Potassium Channels; Scorpion Venoms; Tetraethylammonium; Tetraethylammonium Compounds | 1994 |
Influence of extracellular Ca2+ on endogenous Cl- channels in Xenopus oocytes.
Topics: Animals; Barium; Calcium; Chloride Channels; Egtazic Acid; Electric Conductivity; Female; Flufenamic Acid; Magnesium; Membrane Potentials; Niflumic Acid; Oocytes; Patch-Clamp Techniques; Potassium; Xenopus laevis | 1995 |
Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium.
Topics: Amino Acid Sequence; Animals; Base Sequence; Brain Chemistry; Bungarotoxins; Calcium; Cations; Chloride Channels; Cloning, Molecular; Electric Conductivity; Female; Flufenamic Acid; Ion Channels; Membrane Proteins; Molecular Sequence Data; Niflumic Acid; Oocytes; Permeability; Rats; Receptors, Nicotinic; RNA, Messenger; Sodium Chloride; Tissue Distribution; Transfection; Xenopus laevis | 1993 |
Vasoactive intestinal peptide stimulates a cAMP-mediated Cl- current in avian salt gland cells.
Topics: Animals; Chloride Channels; Cyclic AMP; Ducks; Electric Conductivity; Flufenamic Acid; Membrane Potentials; Niflumic Acid; Salt Gland; Stimulation, Chemical; Thionucleotides; Vasoactive Intestinal Peptide | 1994 |
Differential modulation of alpha 3 beta 2 and alpha 3 beta 4 neuronal nicotinic receptors expressed in Xenopus oocytes by flufenamic acid and niflumic acid.
Topics: Animals; Chloride Channels; Dose-Response Relationship, Drug; Female; Flufenamic Acid; Gene Expression Regulation; Neurons; Niflumic Acid; Oocytes; Patch-Clamp Techniques; Receptors, Nicotinic; Recombinant Fusion Proteins; Xenopus laevis | 1995 |
Positive regulation by chloride channel blockers of IsK channels expressed in Xenopus oocytes.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Calcium; Chloride Channels; Flufenamic Acid; Humans; Mefenamic Acid; Membrane Potentials; Niflumic Acid; Oocytes; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Recombinant Proteins; RNA, Complementary; Xenopus | 1994 |
Comparison of the effects of fenamates on Ca-activated chloride and potassium currents in rabbit portal vein smooth muscle cells.
Topics: Animals; Calcium; Chloride Channels; Evoked Potentials; Female; Flufenamic Acid; In Vitro Techniques; Mefenamic Acid; Membrane Potentials; Molecular Structure; Muscle, Smooth, Vascular; Niflumic Acid; Portal Vein; Potassium Channels; Rabbits | 1995 |
Downregulation of volume-activated Cl- currents during muscle differentiation.
Topics: Animals; Cell Differentiation; Cell Division; Cell Line; Chlorides; Electric Conductivity; Flufenamic Acid; Mice; Muscles; Niflumic Acid; Nitrobenzoates | 1997 |
Unexpected and differential effects of Cl- channel blockers on the Kv4.3 and Kv4.2 K+ channels. Implications for the study of the I(to2) current.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Calcium; Chloride Channels; Dogs; Flufenamic Acid; Humans; Ion Transport; Niflumic Acid; Oocytes; Potassium Channels; Rats; Xenopus | 1997 |
Functional expression of a truncated Ca(2+)-activated Cl- channel and activation by phorbol ester.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Calcium; Calcium Channels; Chlorides; Dithiothreitol; Electrophysiology; Flufenamic Acid; In Vitro Techniques; Ion Channel Gating; Ionophores; Molecular Weight; Mutagenesis, Site-Directed; Niflumic Acid; Oocytes; Open Reading Frames; Protein Biosynthesis; Structure-Activity Relationship; Tetradecanoylphorbol Acetate; Xenopus laevis | 1998 |
The ion selectivity of a membrane conductance inactivated by extracellular calcium in Xenopus oocytes.
Topics: Amiloride; Animals; Anions; Anthracenes; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Calcium; Cations; Diuretics; Electric Conductivity; Extracellular Space; Female; Flufenamic Acid; Gadolinium; Gentamicins; Ion Channels; Membrane Potentials; Niflumic Acid; Oocytes; Patch-Clamp Techniques; Potassium Chloride; Sodium Chloride; Tetraethylammonium; Xenopus laevis | 1998 |
A basolateral chloride conductance in rat lingual epithelium.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Calcium; Chloride Channels; Epithelial Cells; Flufenamic Acid; Membrane Potentials; Niflumic Acid; Patch-Clamp Techniques; Rats; Rats, Wistar; Taste Buds; Tongue | 1998 |
The action of flufenamic acid and other nonsteroidal anti-inflammatories on sulfate transport in the isolated perfused rat liver.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Transport; Dose-Response Relationship, Drug; Flufenamic Acid; In Vitro Techniques; Liver; Male; Mefenamic Acid; Naproxen; Niflumic Acid; Perfusion; Piroxicam; Rats; Rats, Wistar; Sulfates; Sulfonamides; Sulfur Radioisotopes; Time Factors | 1999 |
Synthesis and evaluation of inhibitors of transthyretin amyloid formation based on the non-steroidal anti-inflammatory drug, flufenamic acid.
Topics: Amyloid; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Diflunisal; Drug Design; Drug Evaluation, Preclinical; Flufenamic Acid; Humans; Light; Niflumic Acid; Prealbumin; Scattering, Radiation; Structure-Activity Relationship; Sulindac; Tolmetin | 1999 |
Capillary isotachophoretic determination of flufenamic, mefenamic, niflumic and tolfenamic acid in pharmaceuticals.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calibration; Dosage Forms; Electrophoresis; Flufenamic Acid; Mefenamic Acid; Niflumic Acid; ortho-Aminobenzoates; Pharmaceutical Preparations; Reproducibility of Results | 2000 |
Selective inhibition of Cl(-) conductance in toad skin by blockers of Cl(-) channels and transporters.
Topics: Angiogenesis Inhibitors; Animals; Anion Transport Proteins; Anti-Inflammatory Agents, Non-Steroidal; Bufonidae; Bumetanide; Calcium Channel Blockers; Carrier Proteins; Chloride Channels; Chlorides; Cyclooxygenase Inhibitors; Diuretics; Dose-Response Relationship, Drug; Electric Conductivity; Eosine Yellowish-(YS); Flufenamic Acid; Fluorescent Dyes; Furosemide; Mefenamic Acid; Membrane Potentials; Niflumic Acid; Nitrobenzoates; ortho-Aminobenzoates; Patch-Clamp Techniques; Skin | 2001 |
Pharmacological sensitivity of ATP release triggered by photoliberation of inositol-1,4,5-trisphosphate and zero extracellular calcium in brain endothelial cells.
Topics: Adenosine Triphosphate; Animals; Blood-Brain Barrier; Brain; Calcium; Cells, Cultured; Connexin 43; Connexins; Endothelium, Vascular; Extracellular Space; Flufenamic Acid; Gadolinium; Gap Junction beta-1 Protein; Gap Junctions; Glycyrrhetinic Acid; Humans; Inositol 1,4,5-Trisphosphate; Lanthanum; Niflumic Acid; Nitrobenzoates; Oligopeptides; Rats; Ultraviolet Rays | 2003 |
Effects of inhibitors of nonselective cation channels on the acetylcholine-induced depolarization of circular smooth muscle from the guinea-pig stomach antrum.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Acetylcholine; Animals; Female; Flufenamic Acid; Guinea Pigs; Imidazoles; In Vitro Techniques; Ion Channels; Lanthanum; Male; Membrane Potentials; Muscle, Smooth; Nickel; Niflumic Acid; Pyloric Antrum; Quinidine | 2005 |
Thermodynamic properties of flufenamic and niflumic acids--specific and non-specific interactions in solution and in crystal lattices, mechanism of solvation, partitioning and distribution.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Crystallization; Drug Design; Drug Interactions; Energy Transfer; Flufenamic Acid; Molecular Structure; Niflumic Acid; Solubility; Solutions; Solvents; Thermodynamics | 2007 |
Glucuronidation of fenamates: kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Flufenamic Acid; Glucuronides; Glucuronosyltransferase; Humans; Kidney; Kidney Cortex; Kinetics; Mefenamic Acid; Microsomes; Niflumic Acid; ortho-Aminobenzoates; Recombinant Proteins; UDP-Glucuronosyltransferase 1A9 | 2007 |
Mechanism of interaction of niflumic acid with heterologously expressed kidney CLC-K chloride channels.
Topics: Animals; Chloride Channels; Drug Synergism; Flufenamic Acid; Humans; Kidney; Models, Biological; Niflumic Acid; Phenylpropionates; Rats; Xenopus laevis | 2007 |
Angiotensin II-stimulated Ca2+ entry mechanisms in afferent arterioles: role of transient receptor potential canonical channels and reverse Na+/Ca2+ exchange.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Arterioles; Calcium; Flufenamic Acid; Kidney; Male; Microcirculation; Muscle, Smooth, Vascular; Niflumic Acid; Rats; Rats, Sprague-Dawley; Ryanodine; Sodium-Calcium Exchanger; Thiourea; TRPC Cation Channels | 2008 |
ACh-induced depolarization in inner ear artery is generated by activation of a TRP-like non-selective cation conductance and inactivation of a potassium conductance.
Topics: Acetylcholine; Amiloride; Animals; Anti-Inflammatory Agents; Ear, Inner; Electric Conductivity; Flufenamic Acid; Guinea Pigs; Indoles; Membrane Potentials; Myocytes, Smooth Muscle; Nifedipine; Niflumic Acid; Potassium; Pyridines | 2008 |
Flufenamic acid is a tool for investigating TRPC6-mediated calcium signalling in human conditionally immortalised podocytes and HEK293 cells.
Topics: Boron Compounds; Calcium; Calcium Signaling; Cell Line, Transformed; Flufenamic Acid; Humans; Imidazoles; Indomethacin; Intracellular Space; Ion Channel Gating; Niflumic Acid; Podocytes; Transfection; TRPC Cation Channels; TRPC6 Cation Channel | 2009 |
Induction of pacemaker currents by DA-9701, a prokinetic agent, in interstitial cells of Cajal from murine small intestine.
Topics: Animals; Calcium; Female; Flufenamic Acid; Gastrointestinal Agents; Gastrointestinal Motility; Intestine, Small; Male; Membrane Potentials; Mice; Mice, Inbred BALB C; Niflumic Acid; Patch-Clamp Techniques; Plant Preparations; Type C Phospholipases | 2009 |
Modulation of glutamate and glycine transporters by niflumic, flufenamic and mefenamic acids.
Topics: Amino Acid Transport System X-AG; Animals; Dose-Response Relationship, Drug; Female; Flufenamic Acid; Glycine Plasma Membrane Transport Proteins; Mefenamic Acid; Membrane Potentials; Niflumic Acid; Xenopus laevis | 2009 |
Thermodynamic and structural study of tolfenamic acid polymorphs.
Topics: Buffers; Calorimetry, Differential Scanning; Flufenamic Acid; Hydrogen Bonding; Hydrogen-Ion Concentration; Ions; Models, Chemical; Niflumic Acid; ortho-Aminobenzoates; Pressure; Solubility; Solutions; Solvents; Temperature; Thermodynamics | 2009 |
Solubility of sparingly soluble drug derivatives of anthranilic acid.
Topics: 1-Octanol; Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Diclofenac; Ethanol; Flufenamic Acid; Hydrogen Bonding; Hydrogen-Ion Concentration; Models, Chemical; Molecular Structure; Niflumic Acid; ortho-Aminobenzoates; Solubility; Solvents; Spectrophotometry, Ultraviolet; Thermodynamics; Transition Temperature; Water | 2011 |
Effects of prostaglandin F2α on small intestinal interstitial cells of Cajal.
Topics: Animals; Anti-Inflammatory Agents; Biological Clocks; Calcium; Cells, Cultured; Dinoprost; Enzyme Inhibitors; Flufenamic Acid; Interstitial Cells of Cajal; Intestine, Small; Ion Channels; Membrane Potentials; Mice; Mice, Inbred BALB C; Niflumic Acid; Patch-Clamp Techniques; Type C Phospholipases | 2011 |
Effect of 2-hydroxypropyl-β-cyclodextrin on solubility of sparingly soluble drug derivatives of anthranilic acid.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Flufenamic Acid; Mefenamic Acid; Niflumic Acid; ortho-Aminobenzoates; Solubility; Spectrophotometry, Ultraviolet; Temperature; Thermodynamics | 2011 |
Effects of ginsenoside on pacemaker potentials of cultured interstitial cells of Cajal clusters from the small intestine of mice.
Topics: Action Potentials; Animals; Biological Clocks; Calcium-Transporting ATPases; Cells, Cultured; Chloride Channels; Enzyme Inhibitors; Female; Flufenamic Acid; Gastrointestinal Motility; Ginsenosides; GTP-Binding Proteins; Guanosine Diphosphate; Interstitial Cells of Cajal; Intestine, Small; Male; Membrane Transport Modulators; Mice; Mice, Inbred BALB C; Niflumic Acid; Patch-Clamp Techniques; Protein Kinase C; Thionucleotides; TRPM Cation Channels; Type C Phospholipases | 2012 |
Bestrophin-encoded Ca²⁺-activated Cl⁻ channels underlie a current with properties similar to the native current in the moth Spodoptera littoralis olfactory receptor neurons.
Topics: Amino Acid Sequence; Animals; Arthropod Antennae; Calcium; Cells, Cultured; Chloride Channels; Cloning, Molecular; Cricetinae; Flufenamic Acid; Gene Expression; Gene Expression Regulation, Developmental; Humans; Insect Proteins; Male; Membrane Potentials; Molecular Sequence Data; Niflumic Acid; Nitrobenzoates; Olfactory Receptor Neurons; Organ Specificity; Patch-Clamp Techniques; Permeability; Primary Cell Culture; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Spodoptera | 2012 |
Fenamates block gap junction coupling and potentiate BKCa channels in guinea pig arteriolar cells.
Topics: Animals; Arterioles; Flufenamic Acid; Gap Junctions; Guinea Pigs; In Vitro Techniques; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Niflumic Acid; Potassium Channels, Calcium-Activated | 2013 |
Characterization of the effects of Cl⁻ channel modulators on TMEM16A and bestrophin-1 Ca²⁺ activated Cl⁻ channels.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Anoctamin-1; Bestrophins; Chloride Channels; CHO Cells; Cricetinae; Cricetulus; Eye Proteins; Flufenamic Acid; Humans; Membrane Transport Modulators; Neoplasm Proteins; Niflumic Acid; Nitrobenzoates; Tannins | 2015 |
Cobalt(II) complexes with non-steroidal anti-inflammatory drugs and α-diimines.
Topics: 2,2'-Dipyridyl; Aminopyridines; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Biphenyl Compounds; Cations, Divalent; Cobalt; Coordination Complexes; Crystallography, X-Ray; Diflunisal; DNA; Flufenamic Acid; Free Radical Scavengers; Intercalating Agents; Kinetics; Mefenamic Acid; Methanol; Models, Molecular; Niflumic Acid; Phenanthrolines; Picrates; Serum Albumin | 2016 |
Inhibitors of Calcium-Activated Anion Channels Modulate Hypnotic Ethanol Responses in Adult Sprague Dawley Rats.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Blotting, Western; Brain Chemistry; Calcium Channel Blockers; Calcium Channels; Ethanol; Flufenamic Acid; Hypnotics and Sedatives; Male; Motor Activity; Niflumic Acid; Nitrobenzoates; Rats; Rats, Sprague-Dawley; Reflex, Righting | 2016 |
Exploring TEAD2 as a drug target for therapeutic intervention of cancer: A multi-computational case study.
Topics: Binding Sites; Crystallization; DNA-Binding Proteins; Drug Discovery; Flufenamic Acid; Humans; Hydrophobic and Hydrophilic Interactions; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Targeted Therapy; Neoplasms; Niflumic Acid; Pharmaceutical Preparations; Protein Binding; TEA Domain Transcription Factors; Transcription Factors | 2021 |